From: Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
Objective responses
Number (%)
Overall response rate
Overall tumor control rate
Complete Response
2 (4.7%)
19 (45.2%)
32 (76.2%)
Partial Response
17 (40.5%)
Stable Disease
13 (31.0%)
Disease Progression
10 (23.8%)